Endocarditis infecciosa debida a candida lusitaniae en un lactante menor: Reporte de caso
Introduction: Fungal infective endocarditis is an aggressive and infrequent disease, considered an emergency in hospital services. Candida mortality is around 50-80% in all cases. The Candida lusitaniae mainly affects immunocompromised patients with chronic venous access and the use of broad-spectru...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Asociación Colombiana de Infectología,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_ba07a777876a47218468d58bc385422d | ||
042 | |a dc | ||
100 | 1 | 0 | |a José Darío Portillo-Miño |e author |
245 | 0 | 0 | |a Endocarditis infecciosa debida a candida lusitaniae en un lactante menor: Reporte de caso |
260 | |b Asociación Colombiana de Infectología, |c 2020-06-01T00:00:00Z. | ||
500 | |a 10.22354/in.v24i4.888 | ||
500 | |a 0123-9392 | ||
520 | |a Introduction: Fungal infective endocarditis is an aggressive and infrequent disease, considered an emergency in hospital services. Candida mortality is around 50-80% in all cases. The Candida lusitaniae mainly affects immunocompromised patients with chronic venous access and the use of broad-spectrum antibiotics. Case report: A minor infant is presented who is diagnosed with fungemia and infective endocarditis due to Candida lusitaniae in a native valve secondary to surgery by transposition of large vessels. Discussion and Conclusions: Candida lusitaniae infectious endocarditis is very rare, with a prevalence of less than 2% constituting a challenging scenario in clinical practice. The characteristics of fungemia and endocarditis already defined in the world literature are described. Early detection and a vertiginous therapeutic intervention are essential, since; latent infection, antifungal resistance and delay in diagnosis lead to a threatening condition for the patient's life. | ||
546 | |a EN | ||
546 | |a ES | ||
690 | |a endocarditis | ||
690 | |a candida lusitaniae | ||
690 | |a fungemia | ||
690 | |a equinocandina | ||
690 | |a fluconazole. | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Infectious and parasitic diseases | ||
690 | |a RC109-216 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Infectio, Vol 24, Iss 4, Pp 266-270 (2020) | |
787 | 0 | |n https://www.revistainfectio.org/index.php/infectio/article/view/888 | |
787 | 0 | |n https://doaj.org/toc/0123-9392 | |
856 | 4 | 1 | |u https://doaj.org/article/ba07a777876a47218468d58bc385422d |z Connect to this object online. |